Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/detail.php on line 234

Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 82

Warning: array_push() expects parameter 1 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 85
Pharmalicensing | Life Science's Global Technology Marketplace
Save this technology
Save to Existing Project
Save to a New Project
Tumour Targeted Gene Delivery System
Health Technologies at Strathclyde United Kingdom flag United Kingdom
Abstract ID:
Effective targeting to skin cancer cells has been demonstrated in model systems...
Email me a copy of this message


Cancer is still a leading cause of death worldwide – accounting for about 13% of all deaths. Gene therapy could be highly effective in the treatment of cancer, but is limited by the lack of safe and efficacious delivery systems able to deliver therapeutic genes selectively to tumours by intravenous administration, without secondary effects to healthy tissues. Current gene delivery systems provide only low levels of protein expression in tumours and, in the case of viruses, have been associated with significant toxicity problems. Non-viral delivery systems generally deliver therapeutic DNA to the lung and the liver, but not to the tumours, after intravenous administration.


Researchers at the University of Strathclyde have identified a technique for delivering therapeutic genes to hard-to-reach tumours by intravenous administration without harming healthy tissue. During lab tests the "seek-and-destroy" therapy resulted in 90% of skin cancer tumours disappearing altogether. The team is now investigating the technique's effectiveness at treating different forms of the disease. 

Key Benefits

·         Delivers therapeutic genes efficiently and selectively to tumours following intravenous administration

·         Leaves healthy cells unaffected

·         Fewer side-effects than traditional chemotherapy

Type of Business Relationship Sought

Contact is welcomed from organisations interested in developing, licensing or exploiting this technology.

Last Updated Oct 2013
Technology Type
Phase of Development EARLY STAGE